Mecamylamine adverse reactions: Difference between revisions
(Created page with "__NOTOC__ {{Mecamylamine}} {{CMG}}; {{AE}} {{AK}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VECAMYL (MECAMYLAMINE HYDROCHLORIDE) TABLET...") |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AK}} | {{CMG}}; {{AE}} {{AK}} | ||
==ADVERSE REACTIONS== | |||
The following adverse reactions have been reported and within each category are listed in order of decreasing severity. | |||
'''Gastrointestinal:''' [[Ileus]], [[constipation ]](sometimes preceded by small, frequent liquid stools), [[vomiting]], [[nausea]], [[anorexia]], [[glossitis ]]and dryness of mouth. | |||
'''Cardiovascular:''' Orthostatic [[dizziness ]]and [[syncope]], [[postural hypotension]]. | |||
'''Nervous System/Psychiatric:''' [[Convulsions]], choreiform movements, mental aberrations, [[tremor]], and [[paresthesias ]](see WARNINGS). | |||
'''Respiratory:''' Interstitial [[pulmonary edema ]]and [[fibrosis]]. | |||
'''Urogenital:''' [[Urinary retention]], [[impotence]], decreased [[libido]]. | |||
'''Special Senses:''' [[Blurred vision]], [[dilated pupils]]. | |||
'''Miscellaneous:''' [[Weakness]], [[fatigue]], [[sedation]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VECAMYL (MECAMYLAMINE HYDROCHLORIDE) TABLET [MANCHESTER PHARMACEUTICALS] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6822ce4-e741-4366-b72a-5f5146354f97 | publisher = | date = | accessdate = 10 March 2014 }}</ref> | |||
==References== | ==References== |
Revision as of 14:49, 10 March 2014
Mecamylamine |
---|
Mecamylamine tablet®, Vecamyl® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings |
Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on Mecamylamine |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
ADVERSE REACTIONS
The following adverse reactions have been reported and within each category are listed in order of decreasing severity.
Gastrointestinal: Ileus, constipation (sometimes preceded by small, frequent liquid stools), vomiting, nausea, anorexia, glossitis and dryness of mouth.
Cardiovascular: Orthostatic dizziness and syncope, postural hypotension.
Nervous System/Psychiatric: Convulsions, choreiform movements, mental aberrations, tremor, and paresthesias (see WARNINGS).
Respiratory: Interstitial pulmonary edema and fibrosis.
Urogenital: Urinary retention, impotence, decreased libido.
Special Senses: Blurred vision, dilated pupils.
Miscellaneous: Weakness, fatigue, sedation.[1]
References
- ↑ "VECAMYL (MECAMYLAMINE HYDROCHLORIDE) TABLET [MANCHESTER PHARMACEUTICALS]". Retrieved 10 March 2014.